BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michalski JE, Kurche JS, Schwartz DA. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? Transl Res 2021:S1931-5244(21)00243-7. [PMID: 34547499 DOI: 10.1016/j.trsl.2021.09.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Z, Peng F, Zhou Y. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19? Chinese Medical Journal - Pulmonary and Critical Care Medicine 2023. [DOI: 10.1016/j.pccm.2022.12.002] [Reference Citation Analysis]
2 Gao X, Wei T, Wang H, Sui R, Liao J, Sun D, Han D. Causal associations between obstructive sleep apnea and COVID-19: A bidirectional Mendelian randomization study. Sleep Med 2023;101:28-35. [PMID: 36334498 DOI: 10.1016/j.sleep.2022.09.013] [Reference Citation Analysis]
3 Tlatelpa-Romero B, Cázares-Ordoñez V, Oyarzábal LF, Vázquez-de-Lara LG. The Role of Pulmonary Surfactant Phospholipids in Fibrotic Lung Diseases. Int J Mol Sci 2022;24. [PMID: 36613771 DOI: 10.3390/ijms24010326] [Reference Citation Analysis]
4 Panopoulos S, Tzilas V, Bournia V, Karamanakos A, Laskari K, Bouros D, Tektonidou M, Sfikakis PP. COVID-19 and protection of vaccination in patients with systemic sclerosis–associated interstitial lung disease. Journal of Scleroderma and Related Disorders 2022. [DOI: 10.1177/23971983221143252] [Reference Citation Analysis]
5 Leshchenko IV, Glushkova TV. Clinical and functional characteristics of the post-COVID period (6-month follow-up). Pulʹmonologiâ (Mosk ) 2022;32:795-805. [DOI: 10.18093/0869-0189-2022-32-6-795-805] [Reference Citation Analysis]
6 Chen Y, Qin Y, Fu Y, Gao Z, Deng Y. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients. Int J Mol Sci 2022;23. [PMID: 36555339 DOI: 10.3390/ijms232415698] [Reference Citation Analysis]
7 He S, Wu K, Cheng Z, He M, Hu R, Fan N, Shen L, Li Q, Fan H, Tong Y. Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions. MedComm 2022;3. [DOI: 10.1002/mco2.196] [Reference Citation Analysis]
8 Bartlett NW, Bastarache JA, Kuebler WM, Schmidt EP. Call for Papers: "In It for the Long Haul: Understanding the Lasting Impact of COVID-19 on Lung Health and Disease". Am J Physiol Lung Cell Mol Physiol 2022;323:L683-4. [PMID: 36346147 DOI: 10.1152/ajplung.00352.2022] [Reference Citation Analysis]
9 Zhang T, Zhang J, Lv C, Li H, Song X. Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1059434] [Reference Citation Analysis]
10 Mingote Á, Marrero García R, Santos González M, Castejón R, Salas Antón C, Vargas Nuñez JA, García-Fernández J. Individualizing mechanical ventilation: titration of driving pressure to pulmonary elastance through Young's modulus in an acute respiratory distress syndrome animal model. Crit Care 2022;26:316. [PMID: 36258235 DOI: 10.1186/s13054-022-04184-w] [Reference Citation Analysis]
11 Islam MA, Getz M, Macklin P, Versypt ANF. An agent-based modeling approach for lung fibrosis in response to COVID-19. bioRxiv 2022:2022. [PMID: 36238719 DOI: 10.1101/2022.10.03.510677] [Reference Citation Analysis]
12 Zimmermann CM, Baldassi D, Chan K, Adams NBP, Neumann A, Porras-Gonzalez DL, Wei X, Kneidinger N, Stoleriu MG, Burgstaller G, Witzigmann D, Luciani P, Merkel OM. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery. J Control Release 2022;351:137-50. [PMID: 36126785 DOI: 10.1016/j.jconrel.2022.09.021] [Reference Citation Analysis]
13 Zhong H, Zhou Y, Mei SY, Tang R, Feng JH, He ZY, Xu QY, Xing SP. Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis. Front Public Health 2022;10:967829. [PMID: 36203683 DOI: 10.3389/fpubh.2022.967829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Papageorgiou L, Papakonstantinou E, Diakou I, Pierouli K, Dragoumani K, Bacopoulou F, Chrousos GP, Eliopoulos E, Vlachakis D. Semantic and population analysis of the genetic targets related to COVID-19 and its association with genes and diseases.. [DOI: 10.1101/2022.09.16.508278] [Reference Citation Analysis]
15 Cherrez-ojeda I, Cortés-telles A, Gochicoa-rangel L, Camacho-leon G, Mautong H, Robles-velasco K, Faytong-haro M. Challenges in the Management of Post-COVID-19 Pulmonary Fibrosis for the Latin American Population. JPM 2022;12:1393. [DOI: 10.3390/jpm12091393] [Reference Citation Analysis]
16 Mokra D, Adamcakova J, Mokry J. Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases? Antioxidants (Basel) 2022;11:1566. [PMID: 36009285 DOI: 10.3390/antiox11081566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mingote Á, García RM, González MS, Díaz RC, Antón CS, Nuñez JAV, García-fernández J. Individualizing mechanical ventilation: Titration of driving pressure to pulmonary elastance through Young’s modulus in an acute respiratory distress syndrome animal model.. [DOI: 10.21203/rs.3.rs-1918159/v1] [Reference Citation Analysis]
18 Doan LH, Chu L, Huang Z, Nguyen AT, Lee C, Huang C, Chang Y, Hsieh W, Nguyen TTH, Lin C, Su C, Chuang T, Lai J, Wang F, Yang C, Liu H, Ping Y, Huang CF. Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2. Front Pharmacol 2022;13:905197. [DOI: 10.3389/fphar.2022.905197] [Reference Citation Analysis]
19 Dempsey OJ. Half a billion cases of COVID-19 and counting: Are we facing a new lung fibrosis pandemic, and can we treat it? Journal of the Royal College of Physicians of Edinburgh 2022;52:90-2. [DOI: 10.1177/14782715221104857] [Reference Citation Analysis]
20 Ruggiero V, Aquino RP, Del Gaudio P, Campiglia P, Russo P. Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection. Pharmaceutics 2022;14:1135. [DOI: 10.3390/pharmaceutics14061135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Jindal SK. Post-COVID Pulmonary Fibrosis: A Medical Quagmire? The Indian Journal of Chest Diseases and Allied Sciences 2022;64:5-7. [DOI: 10.5005/ijcdas-64-1-5] [Reference Citation Analysis]
22 Wang Z, Zhang Y, Yang R, Wang Y, Guo J, Sun R, Zhou Y, Su L, Ge Q, Feng Y. Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development. Front Immunol 2022;13:831194. [PMID: 35558069 DOI: 10.3389/fimmu.2022.831194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Hammad R, Kotb HG, Eldesoky GA, Mosaad AM, El-nasser AM, Abd El Hakam FE, Eldesoky NA, Mashaal A, Farhoud H. Utility of Monocyte Expression of HLA-DR versus T Lymphocyte Frequency in the Assessment of COVID-19 Outcome. IJGM 2022;Volume 15:5073-87. [DOI: 10.2147/ijgm.s359690] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Xiang M, Jing H, Wang C, Novakovic VA, Shi J. Persistent Lung Injury and Prothrombotic State in Long COVID. Front Immunol 2022;13:862522. [PMID: 35464473 DOI: 10.3389/fimmu.2022.862522] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Chiner-Vives E, Cordovilla-Pérez R, de la Rosa-Carrillo D, García-Clemente M, Izquierdo-Alonso JL, Otero-Candelera R, Pérez-de Llano L, Sellares-Torres J, de Granda-Orive JI. Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases. Arch Bronconeumol 2022;58 Suppl 1:39-50. [PMID: 35501222 DOI: 10.1016/j.arbres.2022.03.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
26 Margaria JP, Moretta L, Alves-filho JC, Hirsch E. PI3K Signaling in Mechanisms and Treatments of Pulmonary Fibrosis Following Sepsis and Acute Lung Injury. Biomedicines 2022;10:756. [DOI: 10.3390/biomedicines10040756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
27 Bergantini L, Mainardi A, d’Alessandro M, Cameli P, Bennett D, Bargagli E, Sestini P. Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review. Front Pharmacol 2022;13:748931. [DOI: 10.3389/fphar.2022.748931] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Rossiello F, Jurk D, Passos JF, d’Adda di Fagagna F. Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol. [DOI: 10.1038/s41556-022-00842-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 17.0] [Reference Citation Analysis]